C130H162F17N25O4 — CID 157163616
1-[1-cyclobutyl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-2-yl]propan-1-ol;bis(5-[1-(3-fluorocyclobutyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine);2-methyl-5-(1-methyl-2-propan-2-ylimidazol-4-yl)-3-(trifluoromethyl)pyridine;2-methyl-5-[1-(2-oxaspiro[3.3]heptan-6-yl)-2-propan-2-ylimidazol-4-yl]-3-(trifluoromethyl)pyridine;bis(3-methyl-5-[1-[(1R,5S)-3-(1,4-oxazepan-4-yl)-6-bicyclo[3.1.0]hexanyl]-2-propan-2-ylimidazol-4-yl]pyridin-2-amine) (PubChem CID 157163616) has the molecular formula C130H162F17N25O4 and a molecular weight of 2461.86 g/mol. Its IUPAC name is 1-[1-cyclobutyl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-2-yl]propan-1-ol;bis(5-[1-(3-fluorocyclobutyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine);2-methyl-5-(1-methyl-2-propan-2-ylimidazol-4-yl)-3-(trifluoromethyl)pyridine;2-methyl-5-[1-(2-oxaspiro[3.3]heptan-6-yl)-2-propan-2-ylimidazol-4-yl]-3-(trifluoromethyl)pyridine;bis(3-methyl-5-[1-[(1R,5S)-3-(1,4-oxazepan-4-yl)-6-bicyclo[3.1.0]hexanyl]-2-propan-2-ylimidazol-4-yl]pyridin-2-amine).
| Compound Name | 1-[1-cyclobutyl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-2-yl]propan-1-ol;bis(5-[1-(3-fluorocyclobutyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine);2-methyl-5-(1-methyl-2-propan-2-ylimidazol-4-yl)-3-(trifluoromethyl)pyridine;2-methyl-5-[1-(2-oxaspiro[3.3]heptan-6-yl)-2-propan-2-ylimidazol-4-yl]-3-(trifluoromethyl)pyridine;bis(3-methyl-5-[1-[(1R,5S)-3-(1,4-oxazepan-4-yl)-6-bicyclo[3.1.0]hexanyl]-2-propan-2-ylimidazol-4-yl]pyridin-2-amine) |
|---|---|
| PubChem CID | 157163616 |
| Molecular Formula | C130H162F17N25O4 |
| Molecular Weight | 2461.86 g/mol |
| Exact Mass | 2460.30 |
| IUPAC Name | 1-[1-cyclobutyl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-2-yl]propan-1-ol;bis(5-[1-(3-fluorocyclobutyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine);2-methyl-5-(1-methyl-2-propan-2-ylimidazol-4-yl)-3-(trifluoromethyl)pyridine;2-methyl-5-[1-(2-oxaspiro[3.3]heptan-6-yl)-2-propan-2-ylimidazol-4-yl]-3-(trifluoromethyl)pyridine;bis(3-methyl-5-[1-[(1R,5S)-3-(1,4-oxazepan-4-yl)-6-bicyclo[3.1.0]hexanyl]-2-propan-2-ylimidazol-4-yl]pyridin-2-amine) |
| SMILES | CCC(O)c1nc(-c2cnc(C)c(C(F)(F)F)c2)cn1C1CCC1.Cc1cc(-c2cn(C3[C@H]4CC(N5CCCOCC5)C[C@@H]34)c(C(C)C)n2)cnc1N.Cc1cc(-c2cn(C3[C@H]4CC(N5CCCOCC5)C[C@@H]34)c(C(C)C)n2)cnc1N.Cc1ncc(-c2cn(C)c(C(C)C)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C3CC(F)C3)c(C(C)C)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C3CC(F)C3)c(C(C)C)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C3CC4(COC4)C3)c(C(C)C)n2)cc1C(F)(F)F |
| InChI | InChI=1S/2C23H33N5O.C19H22F3N3O.2C17H19F4N3.C17H20F3N3O.C14H16F3N3/c2*1-14(2)23-26-20(16-9-15(3)22(24)25-12-16)13-28(23)21-18-10-17(11-19(18)21)27-5-4-7-29-8-6-27;1-11(2)17-24-16(8-25(17)14-5-18(6-14)9-26-10-18)13-4-15(19(20,21)22)12(3)23-7-13;2*1-9(2)16-23-15(8-24(16)13-5-12(18)6-13)11-4-14(17(19,20)21)10(3)22-7-11;1-3-15(24)16-22-14(9-23(16)12-5-4-6-12)11-7-13(17(18,19)20)10(2)21-8-11;1-8(2)13-19-12(7-20(13)4)10-5-11(14(15,16)17)9(3)18-6-10/h2*9,12-14,17-19,21H,4-8,10-11H2,1-3H3,(H2,24,25);4,7-8,11,14H,5-6,9-10H2,1-3H3;2*4,7-9,12-13H,5-6H2,1-3H3;7-9,12,15,24H,3-6H2,1-2H3;5-8H,1-4H3/t2*17?,18-,19+,21?;;;;; |
| InChIKey | AMQSQZAMMDQFLC-LGQJZXKVSA-N |
| XLogP | 30.52 |
| TPSA | 321.41 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 176 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2461.86 |
| LogP ≤ 5 | 30.52 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 29 |